192 related articles for article (PubMed ID: 30082769)
1. PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1.
Huo FC; Pan YJ; Li TT; Mou J; Pei DS
Cell Death Differ; 2019 Jun; 26(6):994-1006. PubMed ID: 30082769
[TBL] [Abstract][Full Text] [Related]
2. PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.
Zhu G; Li X; Guo B; Ke Q; Dong M; Li F
Oncogene; 2016 Apr; 35(15):1943-54. PubMed ID: 26212009
[TBL] [Abstract][Full Text] [Related]
3. PAK5 Induces EMT and Promotes Cell Migration and Invasion by Activating the PI3K/AKT Pathway in Ovarian Cancer.
Li D; Pan Y; Huang Y; Zhang P; Fang X
Anal Cell Pathol (Amst); 2018; 2018():8073124. PubMed ID: 30245957
[TBL] [Abstract][Full Text] [Related]
4. Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics.
Li YK; Zou J; Ye DM; Zeng Y; Chen CY; Luo GF; Zeng X
Life Sci; 2020 Jan; 241():117113. PubMed ID: 31805288
[TBL] [Abstract][Full Text] [Related]
5. PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo.
Zhang YC; Huo FC; Wei LL; Gong CC; Pan YJ; Mou J; Pei DS
J Exp Clin Cancer Res; 2017 Oct; 36(1):146. PubMed ID: 29041983
[TBL] [Abstract][Full Text] [Related]
6. PAK5 promotes the cell stemness ability by phosphorylating SOX2 in lung squamous cell carcinomas.
Bao Z; Ji W; Yang Y; Chen Z; Li Z; Wang K; Lu T; Yu Y; Xia W; Lu S
Exp Cell Res; 2020 Oct; 395(2):112187. PubMed ID: 32721391
[TBL] [Abstract][Full Text] [Related]
7. PAK5-Egr1-MMP2 signaling controls the migration and invasion in breast cancer cell.
Wang XX; Cheng Q; Zhang SN; Qian HY; Wu JX; Tian H; Pei DS; Zheng JN
Tumour Biol; 2013 Oct; 34(5):2721-9. PubMed ID: 23696025
[TBL] [Abstract][Full Text] [Related]
8. P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration.
Gong W; An Z; Wang Y; Pan X; Fang W; Jiang B; Zhang H
Int J Cancer; 2009 Aug; 125(3):548-55. PubMed ID: 19415746
[TBL] [Abstract][Full Text] [Related]
9. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
Zhang X; Liu S; Zhu Y
Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
[TBL] [Abstract][Full Text] [Related]
10. PAK5 facilitates the proliferation, invasion and migration in colorectal cancer cells.
Huang S; Zhu Y; Wang C; Li X; Cui X; Tu S; You L; Fu J; Chen Z; Hu W; Gong W
Cancer Med; 2020 Jul; 9(13):4777-4790. PubMed ID: 32383357
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer.
Feng S; Liu W; Bai X; Pan W; Jia Z; Zhang S; Zhu Y; Tan W
Cancer Lett; 2019 Nov; 465():105-117. PubMed ID: 31499118
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
Li YM; Li XJ; Yang HL; Zhang YB; Li JC
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
[TBL] [Abstract][Full Text] [Related]
13. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
14. PAK5 promotes RNA helicase DDX5 sumoylation and miRNA-10b processing in a kinase-dependent manner in breast cancer.
Li Y; Xing Y; Wang X; Hu B; Zhao X; Zhang H; Han F; Geng N; Wang F; Li Y; Li J; Jin F; Li F
Cell Rep; 2021 Dec; 37(12):110127. PubMed ID: 34936874
[TBL] [Abstract][Full Text] [Related]
15. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
17. SATB1 promotes prostate cancer metastasis by the regulation of epithelial-mesenchymal transition.
Mao LJ; Yang CH; Fan L; Gao P; Yang DR; Xue BX; Zheng JN; Shan YX
Biomed Pharmacother; 2016 Apr; 79():1-8. PubMed ID: 27044805
[TBL] [Abstract][Full Text] [Related]
18. The overexpression of P21-activated kinase 5 (PAK5) promotes paclitaxel-chemoresistance of epithelial ovarian cancer.
Li D; Yao X; Zhang P
Mol Cell Biochem; 2013 Nov; 383(1-2):191-9. PubMed ID: 23877225
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway.
Han ZX; Wang XX; Zhang SN; Wu JX; Qian HY; Wen YY; Tian H; Pei DS; Zheng JN
Brain Tumor Pathol; 2014 Oct; 31(4):234-41. PubMed ID: 24062079
[TBL] [Abstract][Full Text] [Related]
20. An oncogenic kinase: putting PAK5 forward.
Wen YY; Zheng JN; Pei DS
Expert Opin Ther Targets; 2014 Jul; 18(7):807-15. PubMed ID: 24869804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]